BAGANBAZAR GRAPHEXPLORE · ANALYZE · GROW
Theme
LiveDesk
BusinessBiocon inks global patent settlement pact with Genentech for breast cancer drug PebrilzoWorldVietnam says trade talks with US nearly completed; US officials more cautiousWorldFuel shortage triggers queues on resort island BaliWorldIndonesia names over 200 people, nine firms as suspects over forest fires as transboundary haze worsensWorldAcross the border, India’s ‘cockroach’ movement draws young Pakistani interest
Business/Source-attributed reporting
Business DESK

Biocon inks global patent settlement pact with Genentech for breast cancer drug Pebrilzo

The patent settlement agreement resolves all pending disputes between the two companies across multiple jurisdictions, including the US and Canada

Published Oct 14, 2026 · 5:30 AMOriginal source: Business Line - Home1 reads
The patent settlement agreement resolves all pending disputes between the two companies across multiple jurisdictions, including the US and Canada
ORIGINAL SOURCE

Business Line - Home

This report is indexed by BAGANBAZAR GRAPH with its original publisher named and linked for readers.

Read at original outlet ↗
RELATED COVERAGE

More from this desk.